Literature DB >> 7460842

Prolactin augmentation of dopamine and norepinephrine release from superfused medial basal hypothalamic fragments.

M M Foreman, J C Porter.   

Abstract

A superfusion technique was employed in the study of the release of dopamine (DA) and norepinephrine (NE) from medial basal hypothalamic fragments. The DA and NE collected in the superfusion fluid were quantified by a radioenzymatic assay. The amounts of DA and NE released by the medial basal hypothalamic fragments were found to be dependent upon the CA2+ and K+ concentrations in the superfusion fluid. The effect of PRL on the amounts of DA and NE released during exposure to a submaximal stimulus of 30 mM K+ was evaluated. PRL in concentrations of 50-5000 ng/ml augmented the K+-induced release of DA and NE in a concentration-dependent manner. The PRL augmentation of the release of both DA and NE was prevented by the addition of anti-PRL gamma-globulin to the superfusion medium. In view of the inhibitory effect of DA on PRL secretion, these findings are consistent with the conclusion that PRL can influence its own secretion by stimulating the release of hypothalamic DA. The observation that PRL can also augment the release of NE is supportive of the view that PRL can influence the secretion of nondopaminergic neurotransmitters within the hypothalamus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7460842     DOI: 10.1210/endo-108-3-800

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

Review 1.  The interaction between mediobasohypothalamic dopaminergic and endorphinergic neuronal systems as a key regulator of reproduction: an hypothesis.

Authors:  D D Rasmussen
Journal:  J Endocrinol Invest       Date:  1991-04       Impact factor: 4.256

2.  Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women.

Authors:  P Fioretti; A Cagnacci; A M Paoletti; M Gambacciani; R Soldani; G A Mauro; A Spinetti; G B Melis
Journal:  J Endocrinol Invest       Date:  1989-05       Impact factor: 4.256

3.  Reduced tuberoinfundibular dopaminergic neuronal function in rats after long-term withdrawal of estrogen treatment.

Authors:  L Annunziato; D Cocchi; G di Renzo; G L Rossi; S Amoroso; M Taglialatela; E E Müller
Journal:  Experientia       Date:  1986-04-15

4.  Prolactin replacement must be continuous and initiated prior to 21 d of age to maintain hypothalamic dopaminergic neurons in hypopituitary mice.

Authors:  Carol J Phelps; Mario I Romero; David L Hurley
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

Review 5.  New concepts in the regulation of hypothalamic gonadotropin releasing hormone (GnRH) secretion.

Authors:  D D Rasmussen
Journal:  J Endocrinol Invest       Date:  1986-10       Impact factor: 4.256

6.  Effect of human prolactin administration on gonadotropin and thyrotropin secretion in normal men.

Authors:  M E Molitch; R W Rebar; C P Barsano
Journal:  J Endocrinol Invest       Date:  1993-09       Impact factor: 4.256

7.  Evaluation of Hypothalamic-Pituitary-Adrenal Axis by the GHRP2 Test: Comparison With the Insulin Tolerance Test.

Authors:  Tomoaki Hayakawa; Tetsuhiro Kitamura; Daisuke Tamada; Kosuke Mukai; Reiko Hayashi; Mitsuyoshi Takahara; Michio Otsuki; Iichiro Shimomura
Journal:  J Endocr Soc       Date:  2018-06-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.